Company AI Risk Explorer
Loading the data…
Welcome to the Company AI Risk Explorer

This tool maps what large global companies say in public about AI risk. We reviewed public documents from roughly 200 of the world's largest companies. We coded every risk they acknowledge against the AI Risk Repository taxonomy.

Filter by company, sector, AI role, or risk. Compare what companies acknowledge against expert ratings of severity, sector vulnerability, and role responsibility.

← Back to the overview Company AI Risk Explorer

Companies × risks

Roche

Roche deploys AI in production healthcare settings through its navify platforms, integrating both Roche and partner algorithms into clinical workflows. Through Genentech, it also develops proprietary ML and generative models for drug discovery, including a next-generation AI platform built with NVIDIA DGX Cloud.

We reviewed 2 public documents from Roche and found it acknowledges 3 of 24 AI risks, including loss of privacy and disinformation & influence.

Sector: Agriculture, Mining, Construction and Manufacturing; Chemicals & pharmaceutical manufacturing

Roles: AI deployer; Specialized AI developer

AI risks Roche acknowledges

  • Loss of privacy: “This reduces the risk of personal identification when AI models are created.” (Roche Artificial Intelligence (AI) Ethics Principles)
  • Disinformation & influence: “Persistent false information (deliberate or unintended) ... significantly alters public opinion, accelerated through the fast rise of artificial intelligence.” (Roche's Annual Report 2024 - Roche)
  • Environmental harm: “Roche is committed to reducing the negative impact of our AI systems on the environment... data is processed efficiently across the life cycle to ensure a small carbon footprint.” (Roche Artificial Intelligence (AI) Ethics Principles)

Documents we reviewed